Innovation is the lifeblood of a specialty company. EBITDA Margins • Focus on organic growth combined with transformative and bolt-on acquisitions • Divested commodity businesses tied to more cyclical end markets • Expanded presence in high growth areas of sustainable solutions, specialty healthcare applications, composites and more resilient end markets 5.4% 11.5% 16.1% 2006 2018 2022PF $142 $408 $585 2006 2018 2022PF 2006 figures exclude joint venture results 19 RETURNING CASH TO SHAREHOLDERS Growing Dividend 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 22 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 0.99 11 12 13 14 15 16 17 18 19 20 21 22 23 ~$1Bn REPURCHASED OVER LAST 11 YEARS ~$550MM PAID OVER LAST 11 YEARS Dividends Share Repurchases Cumulative Buybacks $B n $ p e r sh ar e 2022 PRO FORMA ADJUSTED EPS Earnings Growth Expanding Profitability $0.15 $1.09 $2.08 $2.67 2009 2012 2015 2018 2022PF T H IR D Q UART ER 2022 RE S U LTS $110 $119 $0.61 $0.59 Q3 2022 PERFORMANCE (TOTAL COMPANY CONT. OPS) 21 Sales Adjusted EBITDA $818 $823 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 22 Price increases more than offset raw material and supply chain impacts $ millions CAI: Price / Mix 68 Inflation (44) SEM: Price / Mix 41 Inflation (26) Net Price Benefit 39 Wage and Energy Inflation (14) Clariant Color Integration Synergies 6 Incentives, Other Employee Costs 14 FX (11) Q3 2022 $137   Adjusted Q3 2021 $ 142 Demand (39) Q3 2022 SEGMENT PERFORMANCE 23 CAI $587 $566 Sales $93 $93 SEM Pro Forma $326 $319 Sales $70 $62 (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 $2.60 $2.95 FULL YEAR 2022 GUIDANCE 24 Sales Adjusted EBITDA $3,375 $3,635 Adjusted EPS (in millions) (in millions) 25 SUMMARY • Executed the plans we laid out earlier this year • Completed the Dyneema acquisition and Distribution divestiture amid challenging market conditions • Paid down debt and expect to finish the year modestly levered at 3.1x net debt to 2022 pro forma adjusted EBITDA • Expect $200 million of free cash flow in 2022 • Entering an economic slowdown with a portfolio that is better positioned than ever before • Updated our EPS guidance to $2.60 from continuing operations APPENDIX Performance Additives Pigments TiO2 Dyestuffs 3%Polyethylene 12% Nylon Polypropylene Other Raw 30% Styrenic Block Copolymer ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 27 • From Q2 to Q3, we have seen a 7-10% sequential decline in certain hydrocarbon-based raw materials • Other raw materials such as performance additives and pigments have shown moderate inflation sequentially from Q2 to Q3 Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Avient Protective Materials SEGMENT DATA U.S. & Canada Latin America 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 21% Building and END MARKET REVENUE (1) Total company adjusted EBITDA of $585M includes corporate costs.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise.  PolyOne’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of the Company and each business segment and to allocate resources. Appendix Q3 2014 Financial Highlights At a Glance�Global Color, Additives and Inks At a Glance�Global Specialty Engineered Materials At a Glance�Designed Structures and Solutions At a Glance�Performance Products and Solutions At a Glance�Distribution Plastics: Key to Future Sustainable Development Commitment to Operational Excellence Application Examples Slide Number 28 Anti-Counterfeiting Solutions 2012 Range Rover Evoque Interior Slide Number 31 Metal Replacement Solutions Next Generation Solar Charger High-Barrier Packaging Containers Aerospace Applications Non GAAP Rec - 11 5 14.pdf Sidoti & Company non-GAAP Rec

Innovation is the lifeblood of a specialty company. EBITDA Margins • Focus on organic growth combined with transformative and bolt-on acquisitions • Divested commodity businesses tied to more cyclical end markets • Expanded presence in high growth areas of sustainable solutions, specialty healthcare applications, composites and more resilient end markets 5.4% 11.5% 16.1% 2006 2018 2022PF $142 $408 $585 2006 2018 2022PF 2006 figures exclude joint venture results 19 RETURNING CASH TO SHAREHOLDERS Growing Dividend 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 22 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 0.99 11 12 13 14 15 16 17 18 19 20 21 22 23 ~$1Bn REPURCHASED OVER LAST 11 YEARS ~$550MM PAID OVER LAST 11 YEARS Dividends Share Repurchases Cumulative Buybacks $B n $ p e r sh ar e 2022 PRO FORMA ADJUSTED EPS Earnings Growth Expanding Profitability $0.15 $1.09 $2.08 $2.67 2009 2012 2015 2018 2022PF T H IR D Q UART ER 2022 RE S U LTS $110 $119 $0.61 $0.59 Q3 2022 PERFORMANCE (TOTAL COMPANY CONT. OPS) 21 Sales Adjusted EBITDA $818 $823 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 22 Price increases more than offset raw material and supply chain impacts $ millions CAI: 68Price / Mix (44)Inflation SEM: 41Price / Mix (26)Inflation 39Net Price Benefit (14)Wage and Energy Inflation 6Clariant Color Integration Synergies 14Incentives, Other Employee Costs (11)FX $137 Q3 2022   Adjusted $ 142Q3 2021 (39)Demand Q3 2022 SEGMENT PERFORMANCE 23 CAI $587 $566 Sales $93 $93 SEM Pro Forma $326 $319 Sales $70 $62 (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 $2.60 $2.95 FULL YEAR 2022 GUIDANCE 24 Sales Adjusted EBITDA $3,375 $3,635 Adjusted EPS (in millions) (in millions) 25 SUMMARY • Executed the plans we laid out earlier this year • Completed the Dyneema acquisition and Distribution divestiture amid challenging market conditions • Paid down debt and expect to finish the year modestly levered at 3.1x net debt to 2022 pro forma adjusted EBITDA • Expect $200 million of free cash flow in 2022 • Entering an economic slowdown with a portfolio that is better positioned than ever before • Updated our EPS guidance to $2.60 from continuing operations APPENDIX Performance Additives Pigments TiO2 Dyestuffs 3%Polyethylene 12% Nylon Polypropylene Other Raw 30% Styrenic Block Copolymer ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 27 • From Q2 to Q3, we have seen a 7-10% sequential decline in certain hydrocarbon-based raw materials • Other raw materials such as performance additives and pigments have shown moderate inflation sequentially from Q2 to Q3 Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Avient Protective Materials SEGMENT DATA U.S. & Canada Latin America 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 21% Building and END MARKET REVENUE (1) Total company adjusted EBITDA of $585M includes corporate costs.

HC_Industry bulletin_PDI_final.indd www.polymerdiagnostics.com Industr y Bul let in Comprehensive consulting and testing expertise for medical materials and device companies Committed to Growing with the Medical Industry Since 2009, PDI has invested over $2 million to improve and extend our capabilities to serve our medical materials and device clients. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates. Benefi ts: As a result of side-by-side R&D and laboratory work, the two companies ultimately optimized a proprietary method for bonding the polymer disc and titanium plates.

The company is dedicated to serving customers in diverse industries around the globe, by creating value through collaboration, innovation and an unwavering commitment to excellence.  Investor Relations Contact: Eric R. Investor Contacts

Certificate The SKZ-Cert GmbH Zertifizierungen certifies to the company PolyOne Th.

reporting  companies  that   manufacture  products  (or  have  others  manufacture  products)  that  contain  3TG  metals  or  their  derivatives   (tantalum,  tin,  tungsten  and  gold)  that  are  necessary  to  product  functionality  or  production  are  required  to  assess   their  supply  chains  and  report  to  the  SEC  on  whether  those  materials  are  sourced  from  the  Democratic  Republic  of   Congo  and  adjoining  countries.       As an American Chemistry Council ResponsibleCare® Company and a founding member of the Alliance to End Plastic Waste, we are further committed through our landmark No Surprises PledgeSM and our Sustainability Promise.

Media contact Nicole DeChant Avient Corporation nicole.dechant@avient.com Media Relations Contacts Company Officers

Media Contact Jennifer Huang Avient Corporation jennifer.huang@avient.com Media Relations Contacts Company Officers

Media contact Nicole DeChant  Avient Corporation  nicole.dechant@avient.com Media Relations Contacts Company Officers